Table 3 Study characteristics and results of risk factors for acquiring P. aeruginosa
Author Year | Country (Enrollment Period) | Study Design | Hospital Setting | Type of Funding | Total N | Site of Infection | Source of infection | Case / Exposure | Control / comparator | Mean Age yr | % Male |
|---|---|---|---|---|---|---|---|---|---|---|---|
Araujo 2016 [12] | Brazil (2009–2012; 2014) | CC | Academic | Gov | 236 | Bacteremia 100% | Nosocomial and Community-acquired | MDR-PA | Non-MDR PA | 52.7 | 70.3 |
Cortes 2009 [22] | Colombia (2001–2002) | CC | Gov | NR | 96 | Operation site 31%, RS 31%, BSI 50% | Nosocomial | MDR-PA | Random patients hospitalized the same day | 43.5 | 51 |
DalBen 2013 [23] | Brazil (2000–2002) | PC | Tertiary | Gov; Academic | 325 | NR | Nosocomial | CRPA | NA | 44 | 41 |
Dantas 2014 [15] | Brazil (2009–2011) | RC | Academic | Gov | 120 | BSI 100% | NR | Resistant,MDR-PA and XDR-PA | NA | 51.5 | 63.3 |
Fortaleza 2006 (Study 1) [25] | Brazil (1992–2002) | CC | Academic | NR | 324 | Wound 21.3%, BSI 19.4%, UTI 16.7% | Nosocomial | IRPA or Ceftazidine-resistant PA | Patients without IRPA who were admitted to the same ward | 44.3 | 63 |
Fortaleza 2006 (Study 2) [25] | Brazil (1992–2002) | CC | Academic | NR | 165 | UTI 27.3%, RS 25.5%, wounds 21.8%, | NR | IRPA or Ceftazidine-resistant PA | Patients without IRPA who were admitted to the same ward | 42.3 | 66 |
Furtado 2009 [28] | Brazil (2003–2004) | CC | Academic | NR | 245 | UTI 34.9%; RS 22.2%; catheter tip 20.6% | Nosocomial | IRPA | Patients hospitalized in the same unit and matched to case patients | Median: Cases: 50, Controls: 54 | 61.6 |
Furtado 2010 [24] | Brazil (2006–2008) | CC | Academic | NR | 295 | RS 100% | Nosocomial | IRPA | Patients without PA receiving care in same ICU | 54 | 59.3 |
Gomes 2012 [30] | Brazil (2002–2007) | PCC | Tertiary | Gov | 60 | NR | Nosocomial | MDR-PA | Controls | Median: Cases: 50, Controls: 40 | 66.7 |
Medell 2012 [29] | Cuba (2011) | PC | Tertiary | Gov | 12 | VAP 100% | Nosocomial | PA | NA | 55.5 | NR |
Neves 2010 [18] | Brazil (2004–2005) | Ecological design; RC | Academic | NR | 350 | NR | NR | MDR-PA | NA | NR | NR |
Ossa-Giraldo 2014 [19] | Colombia (2009–2010) | CC | Academic | University Hospital | 140 | NR | Nosocomial | MDR-PA | Susceptible PA | 43.3 | 70 |
Pereira 2008 [27] | Brazil (2000–2002) | CC | Academic | Academic | 59 | UTI 60%, BSI 7%, RS 17% | Nosocomial | IRPA | ISPA | 51.3 | 62.7 |
Rossi 2017 [14] | Brazil (2009–2012) | CC | Academic | University Hospital | 157 | Unknown: 62.42; RS: 17.19; BSI: 13.37 | Nosocomial | CRPA | CSPA | 66.9 | 31.2 |
Royer 2015 [21] | Brazil (2011–2012) | PC | Academic | Gov | 30 | VAP 100% | Nosocomial | CRPA | NA | 58.97 | 80 |
Tuon 2012 [16] | Brazil (2006–2009) | CC | Tertiary | NR | 77 | BSI 100% | Nosocomial | CRPA | CSPA | 47.4 | 23.7 |
Valderrama 2016 [20] | Colombia (2008–2014) | CC | Academic | University Hospital | 168 | RS 30%; GI 26%; Primary 13.7% | Nosocomial | CRPA | CSPA | Cases: 60; Controls: 64.5 | 53 |
Zavascki 2005 (Study1) [26] | Brazil (2002–2003) | CC | Tertiary | Gov | 186 | IRPA:RS 33.4%, UTI 26.9%, Control: NR | Nosocomial | IRPA | Random patients from same unit | 54.5 | 56.5 |
Zavascki 2005 (Study2) [26] | Brazil (2002–2003) | CC | Tertiary | Gov | 158 | IRPA: RS 33.4%, UTI 26.9%, Control: NR | Nosocomial | IRPA | ISPA | 54.7 | 62.7 |